Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cryo Cell International (CCEL) Work In Process (2016 - 2019)

Cryo Cell International's Work In Process history spans 5 years, with the latest figure at $140333.0 for Q1 2019.

  • Quarterly results put Work In Process at $140333.0 for Q1 2019, up 28.34% from a year ago — trailing twelve months through Feb 2019 was $140333.0 (up 28.34% YoY), and the annual figure for FY2018 was $188085.0, up 93.48%.
  • Work In Process for Q1 2019 was $140333.0 at Cryo Cell International, down from $188085.0 in the prior quarter.
  • In the past five years, Work In Process ranged from a high of $188085.0 in Q4 2018 to a low of $70226.0 in Q3 2015.
  • The 5-year median for Work In Process is $116287.0 (2017), against an average of $114010.1.
  • The sharpest move saw Work In Process crashed 50.87% in 2017, then surged 93.48% in 2018.
  • Year by year, Work In Process stood at $134727.0 in 2015, then tumbled by 39.2% to $81912.0 in 2016, then increased by 18.68% to $97210.0 in 2017, then skyrocketed by 93.48% to $188085.0 in 2018, then dropped by 25.39% to $140333.0 in 2019.
  • According to Business Quant data, Work In Process over the past three periods came in at $140333.0, $188085.0, and $132506.0 for Q1 2019, Q4 2018, and Q3 2018 respectively.